Literature DB >> 21110173

A preliminary study on the medical expenditure of Chinese medicine and integrative medicine treatment for influenza A (H1N1) in the fever clinics.

Chuan-jian Lu1, Yi Luo, Hong Zhou, Xiao-lan Qin, Bo-jun Chen, Xue-chun Tang, Hua Deng, Zhao-hui Liang, Ai-hua Ou.   

Abstract

OBJECTIVE: To analyze the effectiveness of Chinese medicine and integrated Chinese and Western medicine for influenza A (H1N1) in the fever clinics and its relevant expenditure.
METHODS: A prospective survey on the clinical epidemic observation and follow-up was conducted from July 2009 to October 2009 with a self-developed questionnaire whose contents including the clinical data of the confirmed 149 H1N1 cases and their relevant therapeutic expenditure. The patients were assigned to the Chinese medicine group (22 cases treated by Chinese medicine alone) and integrative medicine group (124 cases treated by both Chinese medicine and Western medicine). The data were processed with descriptive analysis, t test and χ (2), and sum-rank test.
RESULTS: The proportion of clinical recovery of Chinese medicine group (81.8%) was higher than that of integrative medicine group (54.8%) with statistical significance (P=0.02). The average fever durations in both groups were 3.5 to 4 days, showing no significant difference (P=0.86). In the comparisons of average cost of Chinese herbs, drugs, therapies, and total cost, those of the Chinese medicine group were lower than those in the integrative group (P=0.01, P=0.00, P=0.00, P=0.00).
CONCLUSIONS: The H1N1 patients in the fever clinic who received Chinese medicine treatment had a higher clinical recovery proportion than those who received integrated Chinese and Western medicine treatment with lower medical cost. However, due to small sample size of the Chinese medicine group in the study, the conclusion needs further confirmation by studies with large sample size.

Entities:  

Mesh:

Year:  2010        PMID: 21110173     DOI: 10.1007/s11655-010-0563-4

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  6 in total

1.  Preparing for pandemic influenza: should hospitals stockpile oseltamivir?

Authors:  Sandro Cinti; Carol Chenoweth; Arnold S Monto
Journal:  Infect Control Hosp Epidemiol       Date:  2005-11       Impact factor: 3.254

2.  Financial effects of an influenza pandemic on US hospitals.

Authors:  Jason Matheny; Eric Toner; Richard Waldhorn
Journal:  J Health Care Finance       Date:  2007

3.  Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1).

Authors:  Tim Uyeki
Journal:  N Engl J Med       Date:  2009-11-18       Impact factor: 91.245

4.  Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.

Authors:  Mariana Baz; Yacine Abed; Jesse Papenburg; Xavier Bouhy; Marie-Eve Hamelin; Guy Boivin
Journal:  N Engl J Med       Date:  2009-11-11       Impact factor: 91.245

5.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

6.  Pandemic influenza and hospital resources.

Authors:  Raoul E Nap; Maarten P H M Andriessen; Nico E L Meessen; Tjip S van der Werf
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

  6 in total
  6 in total

Review 1.  Cultural consonance, constructions of science and co-existence: a review of the integration of traditional, complementary and alternative medicine in low- and middle-income countries.

Authors:  Josyula K Lakshmi; Devaki Nambiar; Venkatesh Narayan; Tamysetty N Sathyanarayana; John Porter; Kabir Sheikh
Journal:  Health Policy Plan       Date:  2014-08-28       Impact factor: 3.344

2.  Andrographolide as an anti-H1N1 drug and the mechanism related to retinoic acid-inducible gene-I-like receptors signaling pathway.

Authors:  Bin Yu; Cong-qi Dai; Zhen-you Jiang; En-qing Li; Chen Chen; Xian-lin Wu; Jia Chen; Qian Liu; Chang-lin Zhao; Jin-xiong He; Da-hong Ju; Xiao-yin Chen
Journal:  Chin J Integr Med       Date:  2014-06-28       Impact factor: 1.978

Review 3.  Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics.

Authors:  Román Pérez Velasco; Naiyana Praditsitthikorn; Kamonthip Wichmann; Adun Mohara; Surachai Kotirum; Sripen Tantivess; Constanza Vallenas; Hande Harmanci; Yot Teerawattananon
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

4.  Molecular Mechanism of Dayuan Decoction in the Treatment of Fever Based on Network Pharmacology.

Authors:  Tielin Ye
Journal:  Comput Math Methods Med       Date:  2022-03-25       Impact factor: 2.238

Review 5.  A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.

Authors:  Gina Samaan; Michelle McPherson; Jeffrey Partridge
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

6.  Clinical features and factors associated with outcomes of patients infected with a Novel Influenza A (H7N9) virus: a preliminary study.

Authors:  Xiaorong Chen; Zongguo Yang; Yunfei Lu; Qingnian Xu; Qiang Wang; Liang Chen
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.